To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
AvesthagenAvesthagen (Avestha Gengraine Technologies) is a biotechnology and bioinformatics company located in Bangalore, India, focusing on food, pharmaceuticals, and nutraceuticals. Additional recommended knowledgeAvesthagen was founded in 1998 by Dr Villoo Morawala Patell, who remains Chief Executive Officer of the Company. It currently employs 215 people who focus on research with universities and pharmaceutical companies around the globe. This company has developed natural ingredients derived from plants, that are traditionally used in Indian medicine, and have been proven to be beneficial for conditions such as diabetes, obesity, and metabolic syndrome. The company has successfully secured its first international patents and its subsidiary Avesthagen Quality Agriculture Services ("AQUAS") was an early leader in GMO testing in India. Avesthagen opened a European office in Cambridge in 2004, securing deals that are said to have generated 35% of recent revenue.[1] Mr. Bruce Murdoch, Chief Business Officer joined Avesthagen in October 2006. A former head of schering plough in Indonesia. ShareholdersDanone group (France), bioMérieux (France), Groupe Limagrain (France), Fidelity International (USA), New York Life Investment Management(USA), ICICI Ventures (India), Tata Industries (India), Godrej Industries Ltd(India), Cipla Ltd (India) and Bennett Coleman (India). [2] Notes
|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Avesthagen". A list of authors is available in Wikipedia. |